好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Unique Pattern of Intracranial Calcification: Neuroimaging Signature Distinguishing CSF1R-related Disorder from Autoimmune Encephalopathy
Autoimmune Neurology
P2 - Poster Session 02 (3:00 PM-4:00 PM)
1-020

To define the neuroimaging (MRI+CT) signature of CSF1R-related disorder, to establish imaging discriminators that should prompt early genetic evaluation. 

CSF1R-related disorder usually presents with adult-onset rapidly progressive white matter disease, seizures, and cognitive decline, a phenotype that usually triggers initial autoimmune workup and empiric immunotherapy in clinical practice. Key discriminating imaging features, including parenchymal calcifications and diffusion changes, remain underutilized in autoimmune neurology workflows, contributing to diagnostic delay.

A 37-year-old male presented with a four-year history of progressive neurologic disorder characterized by seizures, asymmetric weakness of extremities, dysarthria, urinary urgency, cognitive decline, and behavioral changes.  Physical exam demonstrated asymmetric spasticity and extrapyramidal involvement with rigidity and dystonia.

Interval MRI brain demonstrated progressive T2 hyperintensities in periventricular and subcortical white matter involving frontal and parietal regions along with the corpus callosum and brain stem. Spine imaging demonstrated longitudinally extensive signal changes in the lateral and dorsal columns. Comprehensive autoimmune evaluation, including MOG-IgG, AQP4-IgG, and CSF analysis was unrevealing. Empiric trial of intravenous methylprednisolone administered elsewhere resulted in no clinical response.  

Review of DWI images demonstrated scattered areas of restricted diffusion within involved white matter.  Non-contrast CT revealed callosal calcifications in a characteristic ‘stepping-stone’ pattern. This constellation of imaging finding is incompatible with autoimmune/inflammatory leukoencephalopathy, and is considered characteristic of CSF1R-related disorder. Trio whole genome sequencing confirmed a heterozygous paternally inherited CSF1R variant (p.Ala780Thr, tyrosine kinase domain). Management options were then directed toward hematopoietic stem cell transplantation evaluation alongside spasticity management and multidisciplinary rehabilitation. 

CSF1R-related disorder has clinical and radiological overlap with autoimmune/inflammatory white matter disorders.  Variability in the clinical spectrum and reduced penetrance with the absence of family history often leads to delay in suspicion and diagnostic evaluation.  Identification of the radiologic hallmarks is paramount in prompting early genetic referral and consideration of potential treatment options including hematopoietic stem cell transplantation.   

Authors/Disclosures
Jai Kumar Rajavoor Muniswamy, MBBS
PRESENTER
Dr. Rajavoor Muniswamy has nothing to disclose.
Sidharth Suresh, MD, MBBS (Mayo Clinic Jacksonville) Dr. Suresh has nothing to disclose.
Max Herman, MD (Mayo Clinic) Dr. Herman has nothing to disclose.
Iris V. Marin Collazo, MD (Mayo Clinic) Dr. Marin Collazo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG.
Zbigniew K. Wszolek, MD, FAAN (Mayo Clinic- Jacksonville) Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
Karthik Muthusamy, MBBS (Mayo Clinic) Dr. Muthusamy has nothing to disclose.